<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Cai GP</submitter><funding>Hunan Provincial Science and Technology Department</funding><funding>the innovation-driven project of Central South University</funding><funding>National Natural Science Foundation of China</funding><pagination>e13178</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8828262</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>55(2)</volume><pubmed_abstract>&lt;h4>Objectives&lt;/h4>DNA N6-methyladenine (N6-mA) demethylase Alkbh1 participates in regulating osteogenic differentiation of mesenchymal stem cell (MSCs) and vascular calcification. However, the role of Alkbh1 in bone metabolism remains unclear.&lt;h4>Materials and methods&lt;/h4>Bone marrow mesenchymal stem cells (BMSCs)-specific Alkbh1 knockout mice were used to investigate the role of Alkbh1 in bone metabolism. Western blot, qRT-PCR, and immunofluorescent staining were used to evaluate the expression of Alkbh1 or optineurin (optn). Micro-CT, histomorphometric analysis, and calcein double-labeling assay were used to evaluate bone phenotypes. Cell staining and qRT-PCR were used to evaluate the osteogenic or adipogenic differentiation of BMSCs. Dot blotting was used to detect the level of N6-mA i</pubmed_abstract><journal>Cell proliferation</journal><pubmed_title>Alkbh1-mediated DNA N6-methyladenine modification regulates bone marrow mesenchymal stem cell fate during skeletal aging.</pubmed_title><pmcid>PMC8828262</pmcid><funding_grant_id>81900810</funding_grant_id><funding_grant_id>81770877</funding_grant_id><funding_grant_id>20180033040008</funding_grant_id><funding_grant_id>2020RC2011</funding_grant_id><funding_grant_id>82000811</funding_grant_id><funding_grant_id>82170902</funding_grant_id><pubmed_authors>Wang M</pubmed_authors><pubmed_authors>Jiang TJ</pubmed_authors><pubmed_authors>Cai GP</pubmed_authors><pubmed_authors>Liu YL</pubmed_authors><pubmed_authors>Xiao Y</pubmed_authors><pubmed_authors>Luo LP</pubmed_authors><pubmed_authors>Yuan J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Alkbh1-mediated DNA N6-methyladenine modification regulates bone marrow mesenchymal stem cell fate during skeletal aging.</name><description>&lt;h4>Objectives&lt;/h4>DNA N6-methyladenine (N6-mA) demethylase Alkbh1 participates in regulating osteogenic differentiation of mesenchymal stem cell (MSCs) and vascular calcification. However, the role of Alkbh1 in bone metabolism remains unclear.&lt;h4>Materials and methods&lt;/h4>Bone marrow mesenchymal stem cells (BMSCs)-specific Alkbh1 knockout mice were used to investigate the role of Alkbh1 in bone metabolism. Western blot, qRT-PCR, and immunofluorescent staining were used to evaluate the expression of Alkbh1 or optineurin (optn). Micro-CT, histomorphometric analysis, and calcein double-labeling assay were used to evaluate bone phenotypes. Cell staining and qRT-PCR were used to evaluate the osteogenic or adipogenic differentiation of BMSCs. Dot blotting was used to detect the level of N6-mA i</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Feb</publication><modification>2025-04-25T17:37:21.49Z</modification><creation>2025-04-25T17:37:21.49Z</creation></dates><accession>S-EPMC8828262</accession><cross_references><pubmed>35018683</pubmed><doi>10.1111/cpr.13178</doi></cross_references></HashMap>